Oncology medical news

Headlines

12 Dec 2018 - UK Medical News Melanoma: rechallenge with second and third checkpoint inhibitor is viable
The study by researchers in Leicester will be presented at the ESMO Immuno-oncology Congress in Switzerland this week.
13 Dec 2018 - Oncology Clinical Digest from Front Oncol MIBC: NACT tops ACT for DFS
Complete pathologic response is a significant prognostic factor.
13 Dec 2018 - Oncology Clinical Digest from Ann Surg Oncol Stage II/III rectal cancer: adding neoadjuvant radiation ups LARS risk
FOWARC post hoc analysis shows higher rate vs chemotherapy alone.

Latest Updates

13 Dec 2018 - Oncology Clinical Digest from Oral Oncol HNC: Dutch tool identifies patients likely to need tube feeding in CRT
Simple tool may help identify patients for proactive placement.
13 Dec 2018 - Oncology Clinical Digest from Br J Haematol Aggressive B-cell lymphoma: no EFS benefit for doubled rituximab
12 vs 8 doses failed to boost remission rates among younger patients receiving CHOEP.
13 Dec 2018 - Oncology Clinical Digest from Sleep Insomnia rate doubles with breast cancer diagnosis
Prevalence rises from 8.1% to 17.9%.
13 Dec 2018 - International Medical News A simple spray gel could prevent tumour spread
Researchers have developed a spray which could prevent local and distant tumour recurrence after surgery.
12 Dec 2018 - Oncology Clinical Digest from Br J Haematol FL: are responses still progressively shorter in the rituximab era?
Unmet need persists for therapies extending response duration.
12 Dec 2018 - Oncology Clinical Digest from J Clin Oncol eBCa: adding palbociclib to letrozole slows growth in PALLET
Lack of clinical response boost in PALLET attributed to concurrent reduction in apoptosis.
12 Dec 2018 - Oncology Clinical Digest from Eur Urol mCRPC: cabozantinib fails to reduce bone pain vs MXT + prednisone
COMET-2 terminated after companion trial also showed no survival benefit.
12 Dec 2018 - Oncology Clinical Digest from Lung Cancer NSCLC: RealGiDo confirms safety of afatinib dose reductions
Tolerability-guided dose reductions reduce adverse reactions without compromising efficacy.
12 Dec 2018 - Oncology Clinical Digest from Onco Targets Ther End-stage HCC: adjuvant cinobufotalin boosts OS in meta-analysis
Meta-analysis supports use with TACE.
12 Dec 2018 - Oncology Clinical Digest from Ann Surg Oncol Early tongue SCC: END shows benefit for node-negative disease in Japanese study
Elective node dissection should be considered for deeper tumors.
11 Dec 2018 - UK Medical News Are GPs complying with NICE guidelines on skin cancer excisions?
GP training in identification of subtypes of basal cell carcinoma might be improved, study suggests.
11 Dec 2018 - Oncology Clinical Digest from N Engl J Med CLL: 1L ibrutinib delivers superior PFS vs chemoimmunotherapy
Phase 3 trial of ibrutinib with/without rituximab vs bendamustine-rituximab in older patients.
11 Dec 2018 - Oncology Clinical Digest from JAMA Oncol SCLC: CRT yields better OS in stage I-II vs stage III disease
CONVERT secondary analysis finds once- and twice-daily RT similarly effective for early-stage SCLC.
11 Dec 2018 - Oncology Clinical Digest from Eur Urol IBD tied to risk for prostate cancer
No association was found with metastatic disease.

Related topics

You're leaving Univadis